NCT01375088

Brief Summary

The purpose of this study is to determine whether propolis is effective in the treatment and prevention of radiotherapy induced oral mucositis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Oct 2010

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2010

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2011

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

June 1, 2011

Completed
16 days until next milestone

First Posted

Study publicly available on registry

June 17, 2011

Completed
Last Updated

November 22, 2012

Status Verified

November 1, 2012

Enrollment Period

5 months

First QC Date

June 1, 2011

Last Update Submit

November 21, 2012

Conditions

Keywords

propolismucositisradiotherapycancer

Outcome Measures

Primary Outcomes (1)

  • NCI.CTC Scale

    we use NCI-CTC scale for patients in 2 groups to assess effect of propolis mouth wash on prevention and treatment of mucositis in patients under radiotherapy.We measured signs(size and sypmtoms) of mucositis by NCI-CTC scale and also we assessed the onset of the mucositis to describe the prevention efficacy of propolis.

    9 month

Secondary Outcomes (1)

  • hyposalivation scale

    9 month

Study Arms (2)

placebo mouth wash

PLACEBO COMPARATOR

10 patients swish \& swallow 15 ml placebo mouth wash for at least 5 min from the first session of radiotherapy until the last session

Drug: propolis

propolis

ACTIVE COMPARATOR

10 patients swish \& swallow 15 ml propolis mouth wash for at least 5 min from the first session of radiotherapy until the last session

Drug: propolis

Interventions

15 ml mouth wash 3 times a day for the whole period of radiotherapy for 5 min swish and then swallow

placebo mouth washpropolis

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • need of radiotherapy
  • at least half of the mouth in the field of radiation
  • dose 50 -70 Gy
  • head \& neck malignancy

You may not qualify if:

  • systemic disease
  • FBS \> 150 WBC \> 3000
  • history of radiotherapy
  • need of chemotherapy
  • systemic disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mashhad University of Medical Science

Mashhad, Khorasan Razavi, Iran

Location

MeSH Terms

Conditions

MucositisNeoplasms

Interventions

Propolis

Condition Hierarchy (Ancestors)

GastroenteritisGastrointestinal DiseasesDigestive System DiseasesMouth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Resins, PlantBiopolymersPolymersMacromolecular SubstancesPlant ExudatesBiological ProductsComplex Mixtures

Study Officials

  • arghavan tonkaboni, resident

    oral medicine dep, dental school, mashhad university of medical science

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

June 1, 2011

First Posted

June 17, 2011

Study Start

October 1, 2010

Primary Completion

March 1, 2011

Study Completion

May 1, 2011

Last Updated

November 22, 2012

Record last verified: 2012-11

Locations